General Information of the Compound
| Compound ID |
CP0093895
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[1-[[(3S,4R)-1-(cyclopentanecarbonyl)-4-hydroxy-4-phenylpyrrolidin-3-yl]methyl]piperidin-4-yl]-2-[4-(dimethylsulfamoyl)phenyl]-N-prop-2-enylacetamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C35H48N4O5S
|
||||||||||||||||||
| Molecular Weight |
636.859
|
||||||||||||||||||
| Canonical SMILES |
CN(C)S(=O)(=O)c1ccc(CC(=O)N(CC=C)C2CCN(C[C@H]3CN(C[C@]3(O)c3ccccc3)C(=O)C3CCCC3)CC2)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C35H48N4O5S/c1-4-20-39(33(40)23-27-14-16-32(17-15-27)45(43,44)36(2)3)31-18-21-37(22-19-31)24-30-25-38(34(41)28-10-8-9-11-28)26-35(30,42)29-12-6-5-7-13-29/h4-7,12-17,28,30-31,42H,1,8-11,18-26H2,2-3H3/t30-,35-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
NIDOQXBRHDVNAR-QGRQJHSQSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound